Department of Pharmacology Hosts Talk by Regeneron Executive
Dr. Yancopoulos Discusses Building a Better Biotech
George D. Yancopoulos, M.D., Ph.D., center, president and chief scientific officer of Regeneron, gave an afternoon presentation on July 11 to standing-room-only audience. He presented "Building A Better Biotech: The Story Of Regeneron," sharing the history and successes of Regeneron, the only biopharmaceutical company led by physician-scientists for nearly 30 years that "bet it all on the power of genetics," first mouse genetics, then human genetics.
Salomon Amar, D.D.S., Ph.D., left, provost for biomedical research and chief biomedical research officer, Touro College and University System, director of the Office of Research Administration and professor of pharmacology and microbiology and immunology at NYMC, and professor of dental medicine, Touro College of Dental Medicine at NYMC, and David Raab, right, executive vice president of the Touro College and University System, were on hand to welcome Dr. Yancopoulus. View Dr. Yancopoulos' presentation.
